GERD treatment
New York, June 28, 2000 (Praxis Press) Clinical studies showing the superiority of proton pump inhibitors over histamine-2 receptor antagonists (H2RAs) in the treatment of severe gastroesophageal reflux disease (GERD) have not been extended to patients with the milder nonerosive form of the condition, which accounts for the majority of GERD cases. According to a new study, the proton pump inhibitor lansoprazole is more effective than the H2RA ranitidine or a placebo for milder (nonerosive) form
The Scientist Staff
Jun 27, 2000
New York, June 28, 2000 (